EPD532	Virtual monitoring, evaluation and learning on HIV service accessibility during COVID 19: learnings & best practices	E-poster	Social and behavioural aspects and approaches to COVID-19
EPA032	Virtual memory CD8⁺ T-cells exhibit highly cytotoxic profiles in people with HIV, and are expanded by N-803	E-poster	Cellular immunity; T cell vaccines
EPE397	Virtual HIV counseling: How to access MSM and transgender people in rural areas in Paraguay in the context of the COVID-19 pandemic	E-poster	Impact of COVID-19 on HIV testing services
EPE053	Virological outcomes and ARV switch profiles one year after dolutegravir transition among children in southern Mozambique	E-poster	Implementation science of scaling up HIV treatment
EPB251	Virological failure and acquired drug resistance among ART-experienced people living with HIV in Nepal: a nationally representative surveillance study	E-poster	Resistance to ART
EPE171	Viral suppression levels among newly enrolled ART patients on multi-month dispensing of antiretroviral drugs	E-poster	Differentiated service delivery for HIV testing, prevention and treatment
PESAB08	Viral suppression among adults with HIV receiving dolutegravir-based antiretroviral therapy and 3HP in Kampala, Uganda	Poster exhibition	Tuberculosis: Prevention, diagnosis, treatment
EPC456	Viral sequence-based near real-time cluster monitoring of HIV-1 reveals the impact of the COVID-19 Pandemic on HIV testing in Japan	E-poster	Effects of the COVID-19 on HIV epidemiology and prevention
EPB187	Viral load suppression after intensive adherence counselling among HIV infected adults at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis	E-poster	Adherence
EPE179	Viral load outcomes and factors associated with viral suppression among HIV-positive patients receiving multi-month dispensing of antiretroviral drugs in the context of COVID-19 pandemic: experience from 7 states in Nigeria	E-poster	Differentiated service delivery for HIV testing, prevention and treatment